SENSEONICS HLGS.INC.-001
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabet… Read more
Market Cap & Net Worth: SENSEONICS HLGS.INC.-001 (6L6)
SENSEONICS HLGS.INC.-001 (F:6L6) has a market capitalization of $13.54 Million (€13.19 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #27612 globally and #3024 in its home market, demonstrating a -7.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SENSEONICS HLGS.INC.-001's stock price €0.32 by its total outstanding shares 40800000 (40.80 Million).
SENSEONICS HLGS.INC.-001 Market Cap History: 2017 to 2025
SENSEONICS HLGS.INC.-001's market capitalization history from 2017 to 2025. Data shows change from $92.85 Million to $13.54 Million (-18.01% CAGR).
SENSEONICS HLGS.INC.-001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SENSEONICS HLGS.INC.-001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6L6 by Market Capitalization
Companies near SENSEONICS HLGS.INC.-001 in the global market cap rankings as of March 19, 2026.
Key companies related to SENSEONICS HLGS.INC.-001 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
SENSEONICS HLGS.INC.-001 Historical Marketcap From 2017 to 2025
Between 2017 and today, SENSEONICS HLGS.INC.-001's market cap moved from $92.85 Million to $ 13.54 Million, with a yearly change of -18.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €13.54 Million | -38.14% |
| 2024 | €21.89 Million | +7.53% |
| 2023 | €20.35 Million | -48.70% |
| 2022 | €39.67 Million | -59.79% |
| 2021 | €98.67 Million | +247.29% |
| 2020 | €28.41 Million | -14.06% |
| 2019 | €33.06 Million | -64.44% |
| 2018 | €92.97 Million | +0.14% |
| 2017 | €92.85 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of SENSEONICS HLGS.INC.-001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.54 Million USD |
| MoneyControl | $13.54 Million USD |
| MarketWatch | $13.54 Million USD |
| marketcap.company | $13.54 Million USD |
| Reuters | $13.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.